5 Healthcare Stocks Making Moves After Earnings

3. Eli Lilly and Company (NYSE:LLY)

Number of Hedge Fund Holders: 53

Shares of Eli Lilly and Company (NYSE:LLY) fell for two consecutive trading sessions after missing financial expectations for the second quarter on Thursday, August 4, 2022. The Indiana-based pharmaceutical giant reported adjusted earnings of $1.25 per share, well below $1.85 per share in the year-ago period.

Revenue for the quarter also fell 4 percent versus last year to $6.49 billion. Analysts were expecting Eli Lilly and Company (NYSE:LLY) to earn $1.69 per share on revenue of $6.84 billion.

Eli Lilly and Company (NYSE:LLY) also disclosed its region-wise sales performance. Its U.S. revenue rose 6 percent to $3.93 billion, while revenue outside the U.S. plummeted 16 percent to $2.55 billion in the quarter.

Looking forward, Eli Lilly and Company (NYSE:LLY) lowered its full-year adjusted earnings outlook to a range of $7.90 – $8.05 per share. Previously, it was looking for adjusted earnings between $8.15 – $8.30 per share.